The preclinical research using the adenoviral mediated gene transfer in LDLR knocked out mice, has resulted in successful expression of LDL-receptors in the liver, with a significant decrease in LDL-C levels and regression of atherosclerosis, with no significant adverse events [54,55,56]. Here, LDLR is linked to atherosclerosis.